Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Some Moroccan medicinal plants may contain compounds that can inhibit the virus causing COVID-19.

A mutation in the VDR gene affects hair cycling without needing ligand binding.

Tofacitinib is effective and safe for treating severe alopecia areata.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.